Magnesium for alcohol withdrawal

source extracted confidence: high 2026-04-09
#administration-oral #adult #alcohol-withdrawal-delirium #alcohol-withdrawal-seizures #alcoholic-beverages

Magnesium for alcohol withdrawal

Sarai et al., 2013 | Cochrane Database Syst Rev | Systematic Review

Citation

Sarai Michael, Tejani Aaron M, ... Li Juliana. Magnesium for alcohol withdrawal. Cochrane Database Syst Rev. 2013-Jun-05;2013(6):CD008358. doi:10.1002/14651858.CD008358.pub2

Abstract

BACKGROUND: Patients have been given magnesium to treat or prevent alcohol withdrawal syndrome (AWS). Evidence to support this practice is limited, and is often based on the controversial link between hypomagnesaemia and AWS. OBJECTIVES: To assess the effects of magnesium for the prevention or treatment of AWS in hospitalised adults. SEARCH METHODS: We searched the Cochrane Drugs and Alcohol Group Register of Controlled Trials (August 2012), PubMed (from 1966 to August 2012 ), EMBASE (from 1988 to August 2012), CINAHL (from 1982 to March 2010), Web of Science (1965 to August 2012). We also carried out Internet searches. SELECTION CRITERIA: Randomised or quasi-randomised trials of magnesium for hospitalised adults with, or at risk for, acute alcohol withdrawal. DATA COLLECTION AND ANALYSIS: Two review authors independently extracted data with a standardised data extraction form, contacting the correspondence investigator if the necessary information was not available in the reports. Dichotomous outcomes were analysed by calculating the risk ratio (RR) for each trial, with the uncertainty in each result expressed with a 95% confidence interval (CI). Continuous outcomes were to be analysed by calculating the standardised mean difference (SMD) with 95% CI. For outcomes assessed by scales we compared and pooled the mean score differences from the end of treatment to baseline (post minus pre) in the experimental and control groups. MAIN RESULTS: Four trials involving 317 people met the inclusion criteria. Three trials studied oral magnesium, with doses ranging from 12.5 mmol/day to 20 mmol/day. One trial studied parenteral magnesium (16.24 mEq q6h for 24 hours). Each trial demonstrated a high risk of bias in at least one domain. There was significant clinical and methodological variation between trials.We found no study that measured all of the identified primary outcomes and met the objectives of this review. Only one trial measured clinical symptoms of seizure, delirium tremens or components of the Clinical Institute Withdrawal Assessment for Alcohol (CIWA) score. A single outcome (handgrip strength) in three trials (113 people), was amenable to meta-analysis. There was no significant increase in handgrip strength in the magnesium group (SMD 0.04; 95% CI -0.22 to 0.30). No clinically important changes in adverse events were reported. AUTHORS' CONCLUSIONS: There is insufficient evidence to determine whether magnesium is beneficial or harmful for the treatment or prevention of alcohol withdrawal syndrome.

Key Findings

Four trials involving 317 people met the inclusion criteria. Three trials studied oral magnesium, with doses ranging from 12.5 mmol/day to 20 mmol/day. One trial studied parenteral magnesium (16.24 mEq q6h for 24 hours). Each trial demonstrated a high risk of bias in at least one domain. There was significant clinical and methodological variation between trials.We found no study that measured all of the identified primary outcomes and met the objectives of this review. Only one trial measured cl

Outcomes Measured

  • Requires manual extraction

Population

Field Value
Population See abstract
Sample Size 317
Age Range See abstract
Condition See abstract

MeSH Terms

  • Administration, Oral
  • Adult
  • Alcohol Withdrawal Delirium
  • Alcohol Withdrawal Seizures
  • Alcoholic Beverages
  • Central Nervous System Depressants
  • Ethanol
  • Female
  • Hand Strength
  • Hospitalization
  • Humans
  • Magnesium
  • Magnesium Sulfate
  • Male
  • Middle Aged
  • Randomized Controlled Trials as Topic
  • Substance Withdrawal Syndrome

Evidence Classification

  • Level: Systematic Review
  • Publication Types: Journal Article, Research Support, Non-U.S. Gov't, Systematic Review
  • Vertical: magnesium

Provenance

Source extracted via PubMed E-utilities API on 2026-04-09